Zuckerman GR, Prakash C, Askin MP, Lewis BS. AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology. 2000;118(1):201-221
Zakai NA, French B, Arnold AM. Hemoglobin decline, function, and mortality in the elderly: the Cardiovascular Health Study. Am J Hematol. 2013;88(1):5-9
Ando K, Morita S, Higashi T. Health-related quality of life among Japanese women with iron-deficiency anemia. Qual Life Res. 2006;15(10):1559-1563
Bull-Henry K, Al-Kawas FH. Evaluation of occult gastrointestinal bleeding. Am Fam Physician. 2013;87(6):430-436
Srygley FD, Gerardo CJ, Tran T, Fisher DA. Does this patient have a severe upper gastrointestinal bleed?. JAMA. 2012;307(10):1072-1079
Rockey DC, Auslander A, Greenberg PD. Detection of upper gastrointestinal blood with fecal occult blood tests. Am J Gastroenterol. 1999;94(2):344-350
Konrad G. Dietary interventions for fecal occult blood test screening: systematic review of the literature. Can Fam Physician. 2010;56(3):229-238
Ho JCL, Chan AKC, Lau KK, Chan HHW. 102. Regulation of iron metabolism: poster III. Iron deficiency as a common treatable cause of chronic normocytic anemia. Blood. 2014;124(21):4032
Rimon E, Levy S, Sapir A. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162(4):445-449
Ko CW, Siddique SM, Patel A. AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology. 2020;159(3):1085-1094
Çoban E, Timuraǧaoǧlu A, Meriç M. Iron deficiency anemia in the elderly: prevalence and endoscopic evaluation of the gastrointestinal tract in outpatients. Acta Haematol. 2003;110(1):25-28
Stray N, Weberg R. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scand J Gastroenterol. 2006;41(7):844-850
Raju GS, Gerson L, Das A, Lewis B. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133(5):1697-1717
Pennazio M, Santucci R, Rondonotti E. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology. 2004;126(3):643-653
Khanna A, Ognibene S, Koniaris L. Embolization as first-line therapy for diverticulosis-related massive lower gastrointestinal bleeding: evidence from a meta-analysis. J Gastrointest Surg. 2005;9(3):343-352
Voron T, Rahmi G, Bonnet S. Intraoperative enteroscopy: is there still a role?. Gastrointest Endosc Clin N Am. 2017;27(1):153-170
Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286-1293
Boonpongmanee S, Fleischer DE, Pezzullo JC. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc. 2004;59(7):788-794
Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc. 2008;67(3):422-429
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2018;113(7):1102
Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG clinical guideline: diagnosis and management of small bowel bleeding. Am J Gastroenterol. 2015;110(9):1265-1287
Rossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol. 1993;88(9):1424-1427
Hvid-Jensen HS, Poulsen SH, Agnholt JS. Severe gastrointestinal bleeding in a patient with subvalvular aortic stenosis treated with thalidomide and octreotide: bridging to transcoronary ablation of septal hypertrophy. J Clin Med Res. 2015;7(11):907-910
Levine GN, Bates ER, Bittl JA. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;134(10):e123-e155
Gutermann IK, Niggemeier V, Zimmerli LU, Holzer BM, Battegay E, Scharl M. Gastrointestinal bleeding and anticoagulant or antiplatelet drugs: systematic search for clinical practice guidelines. Medicine (Baltimore). 2015;94(1):e377
Valgimigli M, Frigoli E, Heg D. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021;385(18):1643-1655
Kwon S, Lee SR, Choi EK. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and prior gastrointestinal bleeding. Stroke. 2021;52(2):511-520
Sherwood MW, Nessel CC, Hellkamp AS. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF Trial. J Am Coll Cardiol. 2015;66(21):2271-2281
Ray WA, Chung CP, Murray KT. Association of oral anticoagulants and proton-pump-inhibitor co-therapy with hospitalization for upper gastrointestinal tract bleeding. JAMA. 2018;320(21):2221-2230
Villanueva C, Colomo A, Bosch A. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11-21
Carson JL, Guyatt G, Heddle NM. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316(19):2025-2035
Tan W, Ge ZZ, Gao YJ. Long-term outcome in patients with obscure gastrointestinal bleeding after capsule endoscopy. J Dig Dis. 2015;16(3):125-134
Kim JB, Ye BD, Song Y. Frequency of rebleeding events in obscure gastrointestinal bleeding with negative capsule endoscopy. J Gastroenterol Hepatol. 2013;28(5):834-840
Arai M, Matsumura T, Ohta Y. Long-term prognosis of patients with obscure gastrointestinal bleeding: a retrospective cohort study. Digestion. 2019;100(1):37-44
Kunihara S, Oka S, Tanaka S, Tsuboi A, Otani I, Chayama K. Management of occult obscure gastrointestinal bleeding patients based on long-term outcomes. Therap Adv Gastroenterol. 2018;11:1756284818787408
Lau WY. Intraoperative enteroscopy—indications and limitations. Gastrointest Endosc. 1990;36(3):268-271
Desa LA, Ohri SK, Hutton KA, Lee H, Spencer J. Role of intraoperative enteroscopy in obscure gastrointestinal bleeding of small bowel origin. Br J Surg. 1991;78(2):192-195
Centers for Disease Control and Prevention; US cancer statistics: highlights from 2018 incidence. US Cancer Statistics Data Brief https://www.cdc.gov/cancer/uscs/pdf/USCS-DataBrief-No23-June2021-h.pdf
American Cancer Society; Key statistics for colorectal cancer https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html
National Cancer Institute; Surveillance, Epidemiology, and End Results (SEER) Program; Cancer stat facts: colorectal cancer https://seer.cancer.gov/statfacts/html/colorect.html
Siegel RL, Fedewa SA, Anderson WF. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109(8):27-32
Lieu CH, Renfro LA, de Gramont A. Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program. J Clin Oncol. 2014;32(27):2975-2984
Davidson KW, Barry MJ, Mangione CM. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977
Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. Early-onset colorectal cancer in young individuals. Mol Oncol. 2019;13(2):109-131
Johnson CM, Wei C, Ensor JE. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24(6):1207-1222
Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607
Ballester V, Cruz-Correa M. How and when to consider genetic testing for colon cancer?. Gastroenterology. 2018;155(4):955-959
Bénard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations. World J Gastroenterol. 2018;24(1):124-138
Bibbins-Domingo K, Grossman DC, Curry SJ. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(23):2564-2575
Wolf AMD, Fontham ETH, Church TR. Colorectal cancer screening for average-risk adults:2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458-479
Knudsen AB, Rutter CM, Peterse EFP. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA. 2021;325(19):1998-2011
Vasen HF, Möslein G, Alonso A. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57(5):704-713
Giardiello FM, Allen JI, Axilbund JE. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2014;80(2):197-220
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384-413
Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):746-774
Pilonis ND, Bugajski M, Wieszczy P. Long-term colorectal cancer incidence and mortality after a single negative screening colonoscopy. Ann Intern Med. 2020;173(2):81-91
Lin JS, Piper M, Perdue LA. Evidence Synthesis No. 135. Agency for Healthcare Research and Quality
Inadomi JM, Vijan S, Janz NK. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582
Saltzman JR, Cash BD, Pasha SF. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015;81(4):781-794
Canadian Task Force on Preventive Health Care; Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016;188(5):340-348
Ramdzan AR, Abd Rahim MA, Mohamad Zaki A, Zaidun Z, Mohammed Nawi A. Diagnostic accuracy of FOBT and colorectal cancer genetic testing: a systematic review & meta-analysis. Ann Glob Health. 2019;85(1):70
Hol L, van Leerdam ME, van Ballegooijen M. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62-68
Viana Freitas BR, Kibune Nagasako C, Pavan CR. Immunochemical fecal occult blood test for detection of advanced colonic adenomas and colorectal cancer: comparison with colonoscopy results. Gastroenterol Res Pract. 2013;2013:384561
Sali L, Mascalchi M, Falchini M. Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial. J Natl Cancer Inst. 2016;108(2):djv319
Pickhardt PJ, Correale L, Morra L, Regge D, Hassan C. Journal club: extracolonic findings at CT colonography: systematic review and meta-analysis. AJR Am J Roentgenol. 2018;211(1):25-39
Food and Drug Administration; Approval order Epi proColon: P130001 http://www.accessdata.fda.gov/cdrh_docs/pdf13/P130001C.pdf
Nikolaou S, Qiu S, Fiorentino F, Rasheed S, Tekkis P, Kontovounisios C. Systematic review of blood diagnostic markers in colorectal cancer. Tech Coloproctol. 2018;22(7):481-498
Cash BD, Fleisher MR, Fern S. Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study). Gut. 2021;70(11):2115-2122
Kim NH, Jung YS, Yang HJ. Prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults (20-39 years old). Clin Gastroenterol Hepatol. 2019;17(1):115-122
Goncalves MD, Lu C, Tutnauer J. High-fructose corn syrup enhances intestinal tumor growth in mice. Science. 2019;363(6433):1345-1349
Robsahm TE, Aagnes B, Hjartåker A, Langseth H, Bray FI, Larsen IK. Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J Cancer Prev. 2013;22(6):492-505
Chan DS, Lau R, Aune D. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One. 2011;6(6):e20456
Hu JY, Hu YW, Zhou JJ, Zhang MW, Li D, Zheng S. Consumption of garlic and risk of colorectal cancer: an updated meta-analysis of prospective studies. World J Gastroenterol. 2014;20(41):15413-15422
Aune D, Chan DS, Lau R. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011;343:d6617
Aune D, Lau R, Chan DSM. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol. 2012;23(1):37-45
Waluga M, Zorniak M, Fichna J, Kukla M, Hartleb M. Pharmacological and dietary factors in prevention of colorectal cancer. J Physiol Pharmacol. 2018;69(3):325-336
Sartini M, Bragazzi NL, Spagnolo AM. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective studies. Nutrients. 2019;11(3):694
Bibbins-Domingo K. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(12):836-845
Cook NR, Lee IM, Gaziano JM. Low-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005;294(1):47-55
Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159(2):77-85
Rothwell PM, Wilson M, Elwin CE. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741-1750
Stürmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians’ Health Study. Ann Intern Med. 1998;128(9):713-720
Centers for Disease Control and Prevention; Data and Statistics. Inflammatory bowel disease https://www.cdc.gov/ibd/data-statistics.htm
GBD 2017 Inflammatory Bowel Disease Collaborators; The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17-30
Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563-573
Aamodt G, Bengtson MB, Vatn MH. Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway. BMC Public Health. 2013;13:530
Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(2):265-276
Larsson JK, Sonestedt E, Ohlsson B, Manjer J, Sjöberg K. The association between the intake of specific dietary components and lifestyle factors and microscopic colitis. Eur J Clin Nutr. 2016;70(11):1309-1317
Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26-42
Bernstein CN, Eliakim A, Fedail S. World Gastroenterology Organisation global guidelines inflammatory bowel disease: update August 2015. J Clin Gastroenterol. 2016;50(10):803-818
Perler BK, Ungaro R, Baird G. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol. 2019;19(1):47
Larsson JK, Sjöberg K, Vigren L, Benoni C, Toth E, Olesen M. Chronic non-bloody diarrhoea: a prospective study in Malmö, Sweden, with focus on microscopic colitis. BMC Res Notes. 2014;7:236
Karmiris K, Avgerinos A, Tavernaraki A. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohn’s Colitis. 2016;10(4):429-436
Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MN. Management of arthropathy in inflammatory bowel diseases. Ther Adv Chronic Dis. 2015;6(2):65-77
Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol. 2013;19(46):8571-8579
Troncoso LL, Biancardi AL, de Moraes HV, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 2017;23(32):5836-5848
Lee DW, Koo JS, Choe JW. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol. 2017;23(35):6474-6481
Glickman JN, Odze RD. Does rectal sparing ever occur in ulcerative colitis?. Inflamm Bowel Dis. 2008;14(Suppl 2):S166-S167
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113(4):481-517
Lamb CA, Kennedy NA, Raine T. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106
Miehlke S, Guagnozzi D, Zabana Y. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021;9:13-37
Mosli MH, Zou G, Garg SK. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(6):802-819
Menees SB, Powell C, Kurlander J, Goel A, Chey WD. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 2015;110(3):444-454
Bannaga A, Kelman L, O’Connor M, Pitchford C, Walters JR, Arasaradnam RP. How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes. BMJ Open Gastroenterol. 2017;4(1):e000116
Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(9):1598-1619
Terdiman JP, Gruss CB, Heidelbaugh JJ, Sultan S, Falck-Ytter YT. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn’s disease. Gastroenterology. 2013;145(6):1459-1463
Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK. AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology. 2019;156(3):748-764
Chande N, MacDonald JK, McDonald JW. Methotrexate for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2007;(4):CD006618
Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009;1:235-241
Riddell J, Hillman L, Chiragakis L, Clarke A. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol. 2007;22(10):1589-1593
Pardi DS, Loftus EV, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 2001;120(6):1483-1484
D’haens G, Van Deventer S, Van Hogezand R. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: a European multicenter trial. Gastroenterology. 1999;116(5):1029-1034
Hanauer SB, Feagan BG, Lichtenstein GR. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 2002;359(9317):1541-1549
Fiorino G, Fazio M, Danese S. Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?. Expert Rev Clin Immunol. 2016;12(4):361-363
Sandborn WJ, Colombel JF, Sands BE. Abatacept for Crohn’s disease and ulcerative colitis. Gastroenterology. 2012;143(1):62-69.e4
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275-2285
Esse S, Mason KJ, Green AC, Warren RB. Melanoma risk in patients treated with biologic therapy for common inflammatory diseases. A systematic review and meta-analysis. JAMA Dermatol. 2020;156(7):787-794
Kafil TS, Nguyen TM, MacDonald JK, Chande N. Cannabis for the treatment of ulcerative colitis. Cochrane Database Syst Rev. 2018;(11):CD012954
Nelson R, Liao C, Fichera A, Rubin DT, Pekow J. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):14-20
Su GL, Ko CW, Bercik P. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):697-705
Grammatikopoulou MG, Goulis DG, Gkiouras K. Low FODMAP diet for functional gastrointestinal symptoms in quiescent inflammatory bowel disease: a systematic review of randomized controlled trials. Nutrients. 2020;12(12):3648
Pedersen N, Ankersen DV, Felding M. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017;23(18):3356-3366
Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Nutrition. 2018;45:24-31
Lacy BE, Pimentel M, Brenner DM. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44
O’Moráin C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Br Med J (Clin Res Ed). 1984;288(6434):1859-62
Schwermer M, Fetz K, Längler A, Ostermann T, Zuzak TJ. Complementary, alternative, integrative and dietary therapies for children with Crohn’s disease—a systematic review. Complement Ther Med. 2020;52:102493
Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2018;(4):CD000542
Lewis JD, Sandler RS, Brotherton C. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn’s disease. Gastroenterology. 2021;161(3):837-852.e9
Singh S, Nagpal SJ, Murad MH. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12(2):210-218
Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241-258
Salih A, Widbom L, Hultdin J, Karling P. Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study. Scand J Gastroenterol. 2018;53(2):173-178
Mantzouranis G, Fafliora E, Saridi M. Alcohol and narcotics use in inflammatory bowel disease. Ann Gastroenterol. 2018;31(6):649-658
Rasmussen NF, Bech BH, Rubin KH, Andersen V. Associations between participation in, intensity of, and time spent on leisure time physical activity and risk of inflammatory bowel disease among older adults (PA-IBD): a prospective cohort study. BMC Public Health. 2021;21(1):634
Centers for Disease Control and Prevention; COVID-19 vaccines for moderately to severely immunocompromised people https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html
Ludvigsson JF, Leffler DA, Bai JC. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52
Kabbani TA, Vanga RR, Leffler DA. Celiac disease or non-celiac gluten sensitivity? An approach to clinical differential diagnosis. Am J Gastroenterol. 2014;109(5):741-746
Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and diagnosis of celiac disease. Gastroenterology. 2021;160(1):63-75
Krigel A, Turner KO, Makharia GK, Green PH, Genta RM, Lebwohl B. Ethnic variations in duodenal villous atrophy consistent with celiac disease in the United States. Clin Gastroenterol Hepatol. 2016;14(8):1105-1111
Jansson-Knodell CL, Hujoel IA, West CP. Sex difference in celiac disease in undiagnosed populations: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(10):1954-1968.e13
Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017;112(1):65-76
Bibbins-Domingo K, Grossman DC, Curry SJ. Screening for celiac disease: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(12):1252-1257
Sharma P, Baloda V, Gahlot GP. Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: a systematic review. J Gastroenterol Hepatol. 2019;34(1):74-83
Li M, Yu L, Tiberti C. A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol. 2009;104(1):154-163
Cammarota G, Ianiro G. Endoscopic evaluation of celiac disease. Endosc Int Open. 2016;4(5):E547-E548
Husby S, Murray JA, Katzka DA. AGA clinical practice update on diagnosis and monitoring of celiac disease—changing utility of serology and histologic measures: expert review. Gastroenterology. 2019;156(4):885-889
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-676
Cassisi JE, Ross EJ, Vivier H, James N, Su LC. The impact of a gluten-free diet on celiac disease: a comprehensive evaluation of two cases using NIH patient reported outcome measures (PROMIS, NTCB, and Neuro-QoL). J Clin Psychol Med Settings. 2020;27(3):444-453
Di Nardo G, Villa MP, Conti L. Nutritional deficiencies in children with celiac disease resulting from a gluten-free diet: a systematic review. Nutrients. 2019;11(7):1588
Therrien A, Silvester JA, Leonard MM, Leffler DA, Fasano A, Kelly CP. Enteric-release budesonide may be useful in the management of non-responsive celiac disease. Dig Dis Sci. 2021;66(6):1989-1997
Seiler CL, Kiflen M, Stefanolo JP. Probiotics for celiac disease: a systematic review and meta-analysis of randomized controlled trials. Am J Gastroenterol. 2020;115(10):1584-1595
Tye-Din JA, Galipeau HJ, Agardh D. Celiac disease: a review of current concepts in pathogenesis, prevention, and novel therapies. Front Pediatr. 2018;6:350
Corese J. Hookworm therapy for coeliac disease (NainCeD-3). Clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT02754609
Di Sabatino A, Lenti MV, Corazza GR, Gianfrani C. Vaccine immunotherapy for celiac disease. Front Med (Lausanne). 2018;5:187
Kern F, Struthers JE. Intestinal lactase deficiency and lactose intolerance in adults. JAMA. 1966;195(11):927-930
Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):738-746
Rao DR, Bello H, Warren AP, Brown GE. Prevalence of lactose maldigestion. Influence and interaction of age, race, and sex. Dig Dis Sci. 1994;39(7):1519-1524
Zheng X, Chu H, Cong Y. Self-reported lactose intolerance in clinic patients with functional gastrointestinal symptoms: prevalence, risk factors, and impact on food choices. Neurogastroenterol Motil. 2015;27(8):1138-1146
Varjú P, Gede N, Szakács Z. Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: a meta-analysis. Neurogastroenterol Motil. 2019;31(5):e13527
Misselwitz B, Butter M, Verbeke K, Fox MR. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut. 2019;68(11):2080-2091
Suarez FL, Savaiano DA, Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med. 1995;333(1):1-4
Oak SJ, Jha R. The effects of probiotics in lactose intolerance: a systematic review. Crit Rev Food Sci Nutr. 2019;59(11):1675-1683
Barkun AN, Love J, Gould M, Pluta H, Steinhart H. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Can J Gastroenterol. 2013;27(11):653-659
Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil. 2012;24(11):983-e538
Ludgate SM, Merrick MV. The pathogenesis of post-irradiation chronic diarrhoea: measurement of SeHCAT and B12 absorption for differential diagnosis determines treatment. Clin Radiol. 1985;36(3):275-278
Sadowski DC, Camilleri M, Chey WD. Canadian Association of Gastroenterology clinical practice guideline on the management of bile acid diarrhea. J Can Assoc Gastroenterol. 2020;3(1):e10-e27
Smalley W, Falck-Ytter C, Carrasco-Labra A, Wani S, Lytvyn L, Falck-Ytter Y. AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBSD). Gastroenterology. 2019;157(3):851-854
Sciarretta G, Vicini G, Fagioli G, Verri A, Ginevra A, Malaguti P. Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with ileal dysfunction or diarrhea. Gastroenterology. 1986;91(1):1-9
Sciarretta G, Fagioli G, Furno A. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut. 1987;28(8):970-975
Lyutakov I, Ursini F, Penchev P. Methods for diagnosing bile acid malabsorption: a systematic review. BMC Gastroenterol. 2019;19(1):185
Poley JR, Hofmann AF. Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology. 1976;71(1):38-44
Singh VK, Haupt ME, Geller DE, Hall JA, Quintana Diez PM. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059-7076
Lieb JG, Draganov PV. Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol. 2008;14(20):3149-3158
Lankisch PG, Schmidt I, König H. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42(4):551-554
Carnie LE, Lamarca A, McNamara MG, Bibby N, O’Reilly DA, Valle JW. The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: in need of a new gold-standard. Pancreatology. 2020;20(4):668-675
Sikkens EC, Cahen DL, Koch AD. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013;13(3):238-242
Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013;4(5):223-231
Achufusi TGO, Sharma A, Zamora EA, Manocha D. Small intestinal bacterial overgrowth: comprehensive review of diagnosis, prevention, and treatment methods. Cureus. 2020;12(6):e8860
Rao SSC, Bhagatwala J. Small intestinal bacterial overgrowth: clinical features and therapeutic management. Clin Transl Gastroenterol. 2019;10(10):e00078
Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95(12):3503-3506
Almeida JA, Kim R, Stoita A, McIver CJ, Kurtovic J, Riordan SM. Lactose malabsorption in the elderly: role of small intestinal bacterial overgrowth. Scand J Gastroenterol. 2008;43(2):146-154
Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009;43(2):157-161
Quigley EMM, Murray JA, Pimentel M. AGA clinical practice update on small intestinal bacterial overgrowth: expert review. Gastroenterology. 2020;159(4):1526-1532
Losurdo G, Salvatore D’Abramo F, Indellicati G, Lillo C, Ierardi E, Di Leo A. The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders. Int J Mol Sci. 2020;21(10):3531
Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18(2):8
Pimentel M, Saad RJ, Long MD, Rao SSC. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165-178
Losurdo G, Leandro G, Ierardi E. Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis. J Neurogastroenterol Motil. 2020;26(1):16-28
Zaidel O, Lin HC. Uninvited guests: the impact of small intestinal bacterial overgrowth on nutritional status. Pract Gastroenterol. 2003;27(7):27-34
Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45(5):604-616
Pimentel M, Lembo A, Chey WD. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32
Lauritano EC, Gabrielli M, Scarpellini E. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008;103(8):2031-2035
Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence. J Clin Gastroenterol. 2017;51(4):300-311
Yousefi B, Eslami M, Ghasemian A, Kokhaei P, Salek Farrokhi A, Darabi N. Probiotics importance and their immunomodulatory properties. J Cell Physiol. 2019;234(6):8008-8018
Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol. 2001;280(3):G368-G380
Bures J, Cyrany J, Kohoutova D. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978-2990